Home
IPO Review by Dilip Davda
Menu
Home
Markets
IPO Review by Dilip Davda
India Inc
Economy and Politics
Intellect Views
Brands & Lifestyle
Pages
Home
IPO Review by Dilip Davda
Categories
Home
Markets
IPO Review by Dilip Davda
India Inc
Economy and Politics
Intellect Views
Brands & Lifestyle
Tag:
Injectables
India Inc
Gland Pharma’s Injectables Bet Pays Off in America
Faiyaz Hardwarewala
—
November 8, 2026
comments off
Gland Pharma’s profit rose 58% as US sales jumped 42% and its contract manufacturing business grew 31%. It is another sign that Indian drugmakers with the right product mix are doing well...
Read more »